CYTK FY 2015 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29M-38.9% YoY

Gross Profit

-$18M-61.9% margin

Operating Income

-$37M-130.5% margin

Net Income

-$38M-130.9% margin

EPS (Diluted)

$-0.97

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$4M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$115M

Total Liabilities

$47M

Stockholders' Equity

$69M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$47M	-38.9%
Gross Profit	-$18M	$3M	-805.6%
Operating Income	-$37M	-$15M	-153.5%
Net Income	-$38M	-$15M	-156.0%